src kinase inhibitors pp2 Search Results


90
Biomol GmbH src family kinase inhibitors pp1
Src Family Kinase Inhibitors Pp1, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family kinase inhibitors pp1/product/Biomol GmbH
Average 90 stars, based on 1 article reviews
src family kinase inhibitors pp1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cayman Chemical src kinase inhibitor pp1
Src Kinase Inhibitor Pp1, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src kinase inhibitor pp1/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
src kinase inhibitor pp1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Enzo Biochem src kinases inhibitor pp1
Src Kinases Inhibitor Pp1, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src kinases inhibitor pp1/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
src kinases inhibitor pp1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Merck KGaA src family tyrosine kinase inhibitor pp2
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Src Family Tyrosine Kinase Inhibitor Pp2, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family tyrosine kinase inhibitor pp2/product/Merck KGaA
Average 90 stars, based on 1 article reviews
src family tyrosine kinase inhibitor pp2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Biomol GmbH src family tyrosine kinase inhibitor pp2
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Src Family Tyrosine Kinase Inhibitor Pp2, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family tyrosine kinase inhibitor pp2/product/Biomol GmbH
Average 90 stars, based on 1 article reviews
src family tyrosine kinase inhibitor pp2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cayman Chemical inhibitor of src kinases 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine pp2
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Inhibitor Of Src Kinases 3 (4 Chlorophenyl) 1 (1,1 Dimethylethyl) 1h Pyrazolo[3,4 D]Pyrimidin 4 Amine Pp2, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inhibitor of src kinases 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine pp2/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
inhibitor of src kinases 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine pp2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cosmo Bio USA src kinase inhibitor pp2
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Src Kinase Inhibitor Pp2, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src kinase inhibitor pp2/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
src kinase inhibitor pp2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Biomol GmbH src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (pp2)
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Src Family Kinase Inhibitor 4 Amino 5 (4 Chlorophenyl) 7 (T Butyl)Pyrazolo[3,4 D]Pyrimidine (Pp2), supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (pp2)/product/Biomol GmbH
Average 90 stars, based on 1 article reviews
src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (pp2) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Oncogene Science Inc src kinase inhibitor pp2
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Src Kinase Inhibitor Pp2, supplied by Oncogene Science Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src kinase inhibitor pp2/product/Oncogene Science Inc
Average 90 stars, based on 1 article reviews
src kinase inhibitor pp2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
HFS LTD src-family kinase inhibitor pp2
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Src Family Kinase Inhibitor Pp2, supplied by HFS LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src-family kinase inhibitor pp2/product/HFS LTD
Average 90 stars, based on 1 article reviews
src-family kinase inhibitor pp2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Merck & Co src kinase family inhibitor pp2
CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM <t>PP2</t> were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).
Src Kinase Family Inhibitor Pp2, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src kinase family inhibitor pp2/product/Merck & Co
Average 90 stars, based on 1 article reviews
src kinase family inhibitor pp2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AbMole Bioscience src family kinase inhibitor pp2
CAV1 Promotes BC Lung Metastasis by Activating the <t>Src/FAK/α6β4</t> Pathway in MDA-MB-231 Cells and Simultaneously Activating Src/PI3K Signaling Downstream of α6β4 in Lung Epithelial Cells. a: CCK8 assay was used to detect the optimal acting concentration of the Src inhibitor <t>PP2.</t> b-e: Western blot analysis was performed to detect the expression of CAV1 and integrin Src/FAK/α6β4 signaling pathway after overexpression, knockdown, and addition of PP2. f: Western blot was used to detect the activation of integrin α6β4 downstream signaling in lung epithelial cells. g,h: IHC staining was used to detect the activation of integrin α6β4 downstream signaling PI3K/Src in mice lungs. Bar=100um. Data ware shown as mean ± SD and assessed with One-way ANOVA test. (n=3) (ns stands for non-significant difference; *p<0.05; **p<0.01; ***p<0.001).
Src Family Kinase Inhibitor Pp2, supplied by AbMole Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/src family kinase inhibitor pp2/product/AbMole Bioscience
Average 90 stars, based on 1 article reviews
src family kinase inhibitor pp2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM PP2 were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).

Journal: International Journal of Molecular Sciences

Article Title: CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells

doi: 10.3390/ijms222212417

Figure Lengend Snippet: CD93 triggers the pY774-Cbl-dependent signaling pathway in spreading ECs. ( a ) Cell lysates from early spreading HUVECs pretreated for 30 min with vehicle alone (DMSO) or 10 μM PP2 were analyzed by Western blotting using antibodies against pY774-Cbl and pY418-Src to confirm PP2 activity. Equal loading was confirmed by using anti-Cbl and anti-Src antibodies. ( b ) Quantification of pY774-Cbl phosphorylation levels from independent experiments performed as in ( a ). Values, normalized to Cbl protein levels, represent the percentage of pY774-Cbl levels relative to vehicle-treated cells (DMSO). *** p < 0.001; paired t -test. ( c , d ) HUVECs were transduced with lentiviral particles expressing unrelated (sh-unr) or CD93 shRNA (sh-CD93). Cells were detached from the plate, resuspended in complete growth medium, plated on the substrate, and fixed at early phases of spreading. Cells were analyzed by immunofluorescence using phalloidin, anti-CD93 antibody, and antibodies against pY774-Cbl ( c ) and Crk ( d ). White dot colocalization (wdc) images are shown as indicated. In the wdc pictures, magnification of the squared areas is shown (2.5×). Scale bars, 20 μm. ( e , f ) Quantification of cellular pY774-Cbl ( e ) and Crk ( f ) in the spreading border area (5 μm from the cell edge) of HUVECs transduced and treated as in ( c ) ( n = 14 cells for sh-unr and n = 16 cells for sh-CD93) and ( d ) ( n = 15 cells for sh-unr and n = 14 cells for sh-CD93). Data are presented as scatter plots and the fluorescence intensity of the pY774-Cbl +ve and Crk +ve signals per area is reported as arbitrary units (AU). * p < 0.05; Student t -test ( e ). *** p < 0.001; Mann–Whitney test ( f ).

Article Snippet: The Src family tyrosine kinase inhibitor PP2 was purchased from Merck KGaA.

Techniques: Western Blot, Activity Assay, Phospho-proteomics, Transduction, Expressing, shRNA, Immunofluorescence, Fluorescence, MANN-WHITNEY

CAV1 Promotes BC Lung Metastasis by Activating the Src/FAK/α6β4 Pathway in MDA-MB-231 Cells and Simultaneously Activating Src/PI3K Signaling Downstream of α6β4 in Lung Epithelial Cells. a: CCK8 assay was used to detect the optimal acting concentration of the Src inhibitor PP2. b-e: Western blot analysis was performed to detect the expression of CAV1 and integrin Src/FAK/α6β4 signaling pathway after overexpression, knockdown, and addition of PP2. f: Western blot was used to detect the activation of integrin α6β4 downstream signaling in lung epithelial cells. g,h: IHC staining was used to detect the activation of integrin α6β4 downstream signaling PI3K/Src in mice lungs. Bar=100um. Data ware shown as mean ± SD and assessed with One-way ANOVA test. (n=3) (ns stands for non-significant difference; *p<0.05; **p<0.01; ***p<0.001).

Journal: International Journal of Biological Sciences

Article Title: Breast cancer-derived CAV1 promotes lung metastasis by regulating integrin α6β4 and the recruitment and polarization of tumor-associated neutrophils

doi: 10.7150/ijbs.94153

Figure Lengend Snippet: CAV1 Promotes BC Lung Metastasis by Activating the Src/FAK/α6β4 Pathway in MDA-MB-231 Cells and Simultaneously Activating Src/PI3K Signaling Downstream of α6β4 in Lung Epithelial Cells. a: CCK8 assay was used to detect the optimal acting concentration of the Src inhibitor PP2. b-e: Western blot analysis was performed to detect the expression of CAV1 and integrin Src/FAK/α6β4 signaling pathway after overexpression, knockdown, and addition of PP2. f: Western blot was used to detect the activation of integrin α6β4 downstream signaling in lung epithelial cells. g,h: IHC staining was used to detect the activation of integrin α6β4 downstream signaling PI3K/Src in mice lungs. Bar=100um. Data ware shown as mean ± SD and assessed with One-way ANOVA test. (n=3) (ns stands for non-significant difference; *p<0.05; **p<0.01; ***p<0.001).

Article Snippet: Caveolin1 Y14 phosphorylation was inhibited by the SRC family kinase inhibitor PP2, which was obtained from Abmole Bioscience Inc (Houston, USA).

Techniques: CCK-8 Assay, Concentration Assay, Western Blot, Expressing, Over Expression, Knockdown, Activation Assay, Immunohistochemistry